Consensus M.D.C. Holdings, Inc.

Equities

MDC

US5526761086

Delayed Nyse 04:00:01 2024-04-18 pm EDT 5-day change 1st Jan Change
62.98 USD +0.05% Intraday chart for M.D.C. Holdings, Inc. +0.08% +13.99%

Evolution of the average Target Price on M.D.C. Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0e7dc4565d52c80d6531e9.9UE8957FaXnMfVhndICDX3me_9mprK6fCN1i8xpY6r4.oTcMr_SpIEiuJDYDIcnoGy3sremf1Zn4XbQpukw5u-6UKUvP35ICL4McOw~caed6182b781b1a3f79e025f965230c2
Raymond James Downgrades M.D.C. Holdings to Market Perform From Outperform MT
Evercore ISI Downgrades M.D.C. to In Line From Outperform, Raises Price Target to $63 From $57 MT
Wedbush Raises Price Target on M.D.C. Holdings to $63 From $51 on Acquisition Bid, Maintains Neutral Rating MT
Seaport Upgrades M.D.C. Holdings to Buy From Neutral, Price Target is $49 MT
Raymond James Adjusts Price Target on M.D.C. Holdings to $60 From $55, Maintains Outperform Rating MT
Let's do it again, but without the same old stuff Our Logo
Wedbush Raises M.D.C. Holdings' PT to $51 From $28 After Higher-Than-Expected Q2 Earnings, In Line Sales; Notes Demand Turnaround; Keeps Neutral Rating MT
Raymond James Upgrades M.D.C. to Outperform From Market Perform, Sets Price Target at $55 MT
Seaport Global Initiates M.D.C. Holdings With Neutral Rating MT
JPMorgan Adjusts Price Target on M.D.C. to $27.50 From $30.50, Keeps Underweight Rating MT
JPMorgan Downgrades M.D.C. Holdings to Underweight From Neutral, Adjusts Price Target to $28 From $27 MT
Raymond James Downgrades M.D.C. Holdings to Market Perform From Strong Buy MT
Fitch Affirms MDC Holdings, Inc.'s IDR at 'BBB-'; Outlook Stable AQ
Raymond James Adjusts Price Target on MDC Holdings to $44 From $77, Reiterates Strong Buy Rating MT
Wedbush Cuts Price Target on MDC Holdings to $41 From $56 on Backlog Reset; Neutral Rating Kept MT
JPMorgan Lowers M.D.C. Holdings' Price Target to $38 From $40.50, Maintains Neutral Rating MT
Evercore ISI Adjusts M.D.C. Holdings Price Target to $46 From $70, Maintains Outperform Rating MT
Volatility is rife for Quadruple Witching Day Our Logo
Analyst recommendations: American Express, Bank of America, CVS Health, Morgan Stanley, United Health... Our Logo
Wells Fargo Downgrades MDC Holdings to Underweight From Equalweight; Price Target is $27 MT
Wells Fargo Adjusts M.D.C. Holdings Price Target to $40 From $50, Maintains Equalweight Rating MT
JPMorgan Adjusts Price Target on MDC Holdings to $39 From $49, Maintains Neutral Rating MT
JPMorgan Adjusts MDC Holdings' Price Target to $49 From $66, Maintains Neutral Rating MT
Wedbush Cuts MDC Holdings' Price Target to $56 From $63 After Community Growth Guidance Rescinded; Neutral Rating Kept MT
Raymond James Adjusts Price Target on M.D.C. Holdings to $77 From $79, Maintains Strong Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
62.98 USD
Average target price
54.85 USD
Spread / Average Target
-12.91%
High Price Target
63 USD
Spread / Highest target
+0.03%
Low Price Target
49 USD
Spread / Lowest Target
-22.20%

Consensus detail

Consensus revision (last 18 months)

Analysts covering M.D.C. Holdings, Inc.

Raymond James
Evercore ISI
Wedbush
Seaport Global Securities
JPMorgan Chase
Wells Fargo Securities
Wolfe Research
BofA Securities
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock Market
  2. Equities
  3. MDC Stock
  4. Consensus M.D.C. Holdings, Inc.